These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 33020551)
1. Transcriptome-wide analysis and modelling of prognostic alternative splicing signatures in invasive breast cancer: a prospective clinical study. Wang L; Wang Y; Su B; Yu P; He J; Meng L; Xiao Q; Sun J; Zhou K; Xue Y; Tan J Sci Rep; 2020 Oct; 10(1):16504. PubMed ID: 33020551 [TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma. Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748 [TBL] [Abstract][Full Text] [Related]
3. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data. Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163 [TBL] [Abstract][Full Text] [Related]
4. Characterization of alternative splicing events and prognostic signatures in breast cancer. Han P; Zhu J; Feng G; Wang Z; Ding Y BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer. Li X; Wang Y; Li B; Ma W Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32079071 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases. Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer. Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333 [TBL] [Abstract][Full Text] [Related]
8. Integrative analysis reveals the prognostic value and functions of splicing factors implicated in hepatocellular carcinoma. Wang Y; Yang F; Shang J; He H; Yang Q Sci Rep; 2021 Jul; 11(1):15175. PubMed ID: 34312475 [TBL] [Abstract][Full Text] [Related]
9. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response. Lu J; Wei S; Lou J; Yin S; Zhou L; Zhang W; Zheng S Med Sci Monit; 2020 Jul; 26():e925733. PubMed ID: 32706768 [TBL] [Abstract][Full Text] [Related]
10. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma. Wan Q; Sang X; Jin L; Wang Z Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer. Chen J; Liao Y; Li R; Luo M; Wu G; Tan R; Xiao Z Technol Cancer Res Treat; 2022; 21():15330338221090093. PubMed ID: 35509211 [No Abstract] [Full Text] [Related]
12. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma. Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730 [TBL] [Abstract][Full Text] [Related]
13. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma. Xing L; Zhang X; Tong D DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877 [TBL] [Abstract][Full Text] [Related]
14. RNA processing genes characterize RNA splicing and further stratify colorectal cancer. Lu X; Zhou Y; Meng J; Jiang L; Gao J; Cheng Y; Yan H; Wang Y; Zhang B; Li X; Yan F Cell Prolif; 2020 Aug; 53(8):e12861. PubMed ID: 32596958 [TBL] [Abstract][Full Text] [Related]
15. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma. Zhang D; Duan Y; Wang Z; Lin J Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577 [TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
17. Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data. Zhang D; Zhang W; Sun R; Huang Z Bioengineered; 2021 Dec; 12(1):1091-1110. PubMed ID: 33783315 [TBL] [Abstract][Full Text] [Related]
18. Prognostic alternative mRNA splicing signature in non-small cell lung cancer. Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168 [TBL] [Abstract][Full Text] [Related]
19. The systematic identification of survival-related alternative splicing events and splicing factors in glioblastoma. Peng T; Liu Z; Zhang Y; Liu X; Zhao L; Ma Y; Fan J; Song X; Wang L Ann Hum Genet; 2024 Jul; 88(4):320-335. PubMed ID: 38369937 [TBL] [Abstract][Full Text] [Related]
20. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data. Xu N; Ke ZB; Lin XD; Lin F; Chen SH; Wu YP; Chen YH; Wei Y; Zheng QS Aging (Albany NY); 2020 Mar; 12(6):4996-5009. PubMed ID: 32217810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]